NeoRich BioPharma Tech Co., Limited (OTCPK: PHBI.D)
Health Care · Pharmaceuticals · CA
$0.34
-62.22% today · -83.0% 1Y
NeoRich BioPharma Tech Co., Limited (OTCPK: PHBI.D) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $117.53K and employs 0 people.
Over the last twelve months the share price has lost 83.0%, trading between 0.24 and 7.00.
Tweenvest scores NeoRich BioPharma Tech Co., Limited across four factors: quality 7/100, value 56/100. Its strongest factor is value.
PHBI.D price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $117.53K
- Revenue (TTM)
- $3.00K
- P/E
- —
- EPS
- -0.68
- Dividend yield
- —
- Beta (5Y)
- 1.74
- 52-week high
- $7.00
- 52-week low
- $0.24
- Avg volume (3M)
- —
- Shares outstanding
- 345.67K
- Employees
- 0
- Next earnings
- —
About NeoRich BioPharma Tech Co., Limited
Pharmagreen Biotech Inc. is a biotechnology solutions provider primarily engaged in cultivating young plant stock for the medical cannabis and CBD hemp industries. Established in 2007, the company operates from its base in Coquitlam, Canada.
- ISIN
- US71716C2089
- Listed since
- Aug 15, 2018
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,217.60 | -1.30% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $271.62 | -0.56% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $154.85 | -1.02% |
| Roche Holding AGSWX: ROP | $371.62B | CHF368.20 | -1.50% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.46 | -1.84% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.30 | -0.96% |
Figures last refreshed Aug 18, 2026.